CompoAtlas

Nutrilite Women's 40 + support

Food supplement declared in France, decision dated 14 May 2025

Nutrilite Women's 40 + support (Nutrilite) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Nutrilite
Food business operator placing the product on the market
Access Business Group International B.V.
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
1 comprimé par jour
Directions for use
POSOLOGIE: Prendre 1 comprimé par jour, de préférence au cours d’un repas
Intended populations
Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Os, Articulations, Autre : La vitamine D et le magnésium contribuent au maintien d’une ossature et d’une dentition normales. La vitamine B6 et le magnésium contribuent à une fonction psychologique normale et à réduire la fatigue. La vitamine B6 contribue au métabolisme normal des protéines et du glycogène. Il est enrichi en extraits de sauge, de soja et de safran.

Declaration 268063, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Salvia officinalis L.FeuilleExtrait sec aqueux214 mg
Glycine max. (L.) Merr.GermeExtrait sec alcoolique64 mg
Crocus sativus L.StigmatesExtrait sec alcoolique6 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Destiné uniquement aux adultes • Ce produit n’est pas destiné aux femmes enceintes et allaitantes • Le produit est déconseillé aux femmes ayant des antécédents personnels ou familiaux de cancer du sein • Le produit est déconseillé aux personnes sous antidépresseurs •

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Salvia officinalis L.
    Read the warning, when it applies and the studies cited

    SAGE - SALVIA OFFICINALIS - Buccal

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    SAGE -SALVIA OFFICINALIS Oral

    Cautions and warnings

    Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

  • Glycine max. (L.) Merr.
    Read the warning, when it applies and the studies cited

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Nutrilite

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line